US Fertility Services Market Research Report By Underlying Cause (Male Infertility, Female Infertility) and By Treatment Type (ART, Infertility Drugs)-Forecast to 2035

US Fertility Services Market Overview

The US Fertility Services Market Industry is expected to grow from 10.54(USD Billion) in 2024 to 30.19 (USD Billion) by 2035. The US Fertility Services Market CAGR (growth rate) is expected to be around 10.044% during the forecast period (2025-2035).

Key US Fertility Services Market Trends Highlighted

Numerous reasons have contributed to the notable expansion of the US fertility services industry. The public's growing understanding and acceptance of assisted reproductive technology has proven crucial. Fertility treatments are becoming more attractive due to increased success rates brought about by advancements in medical technology and procedures like in vitro fertilization (IVF) and genetic testing. Additionally, more people are seeking fertility services as a result of the growing tendency of postponed motherhood brought on by lifestyle and job choices. Another issue is the expansion of fertility clinics around the United States, which makes them more accessible to a wider range of people.

There are several opportunities in the US market for fertility services. The potential expansion of telemedicine services, which enable patients to obtain consultations and follow-ups remotely, is one noteworthy topic. Access to reproductive treatments may become easier as a result, especially for people who live in remote places or have mobility issues. Collaborations between technology companies and reproductive clinics can result in creative solutions that optimize services, improving patient care and treatment procedures. Personalized treatment plans have been increasingly popular in recent years, with clinics concentrating on customizing solutions based on each patient's unique genetic and health information.

Additionally, as more women want to preserve their fertility for later use, egg-freezing services are becoming more and more popular. More people are talking about infertility and embracing social acceptability, which promotes conversations that further de-stigmatize asking for help. A surge in service use might result from this greater openness, suggesting favorable market dynamics in the US fertility services industry.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

US Fertility Services Market Drivers

Rising Infertility Rates

The US Fertility Services Market Industry is experiencing significant growth, driven in large part by the rising infertility rates among couples. According to the Centers for Disease Control and Prevention (CDC), one in eight couples of reproductive age in the United States faces difficulty getting pregnant or carrying a pregnancy to term. Factors contributing to this increase include delayed childbearing, lifestyle factors such as obesity, and environmental influences.

With more couples seeking effective solutions, demand for fertility services has surged. The American Society for Reproductive Medicine has noted a 7% annual increase in assisted reproductive technologies (ART) procedures conducted in the country, indicating a robust market. The rising awareness and acceptance of fertility treatments among the population contribute to the expanded growth prospects in the US Fertility Services Market.

Technological Advances in Fertility Treatment

Technological innovation is a key driver in the US Fertility Services Market Industry. Recent developments, such as the refinement of in vitro fertilization (IVF) techniques and the introduction of preimplantation genetic testing (PGT), have significantly increased success rates in fertility treatments. The Society for Assisted Reproductive Technology reports that IVF success rates have nearly doubled over the last decade, now typically reaching around 40% for women under age 35.

As women become more informed about their reproductive options and the effectiveness of these technologies, there is an increase in demand for advanced fertility solutions. This wave of innovation, supported by contributions from organizations such as the Center for Disease Control and the American Society for Reproductive Medicine, is galvanizing growth in the market.

Increased Insurance Coverage for Fertility Treatments

Increasing insurance coverage for fertility services is another important driver in the US Fertility Services Market Industry. Many states are implementing mandates that require insurance plans to offer coverage for infertility treatment. According to the National Conference of State Legislatures, as of 2021, 19 states have laws requiring insurers to cover fertility treatments, which directly impacts accessibility and affordability. This shift has enhanced the willingness of individuals and couples to pursue fertility treatments, reducing out-of-pocket costs and thereby increasing treatment uptake.

Organizations like Resolve: The National Infertility Association advocate for broader insurance coverage, which plays a crucial role in influencing policy and insurance guidelines, thus boosting the US Fertility Services Market.

US Fertility Services Market Segment Insights

Fertility Services Market Underlying Cause Insights  

The US Fertility Services Market demonstrates a robust potential for growth, particularly in the Underlying Cause segment, where the focus encompasses critical aspects of male and female infertility. This segmentation highlights the increasing awareness and diagnosis of infertility issues among couples, driving the demand for effective fertility treatment solutions. Male infertility is often linked to factors such as low sperm count and motility, which have gained attention in recent years due to lifestyle changes and environmental influences. The significance of this issue cannot be understated, as a substantial percentage of infertility cases are attributed to male-related factors, leading to a demand for specialized treatments and tests tailored to address these concerns.

On the other hand, female infertility remains a major challenge, with age-related factors playing a crucial role in a woman’s ability to conceive, as fertility tends to decline significantly as women age. Conditions such as polycystic ovary syndrome (PCOS) and endometriosis further complicate female reproductive health, necessitating advanced medical interventions. Consequently, the US Fertility Services Market data indicates a growing investment in research and innovative treatment options aimed at tackling both male and female infertility effectively. These developments are encouraging not only from a medical perspective but also in terms of emotional support for couples experiencing difficulty in conceiving.

Overall, the focus on the Underlying Cause segment reflects the changing landscape of reproductive health in the US, as healthcare providers increasingly recognize the need for comprehensive fertility evaluations that encompass both partners. The rising trend of specialist clinics and personalized treatment plans caters to the nuanced needs of individuals facing fertility challenges. Government initiatives supporting reproductive health awareness further bolster growth within this segment, aligning with broader healthcare objectives aimed at improving family planning outcomes across the nation. The US Fertility Services Market segmentation thus plays a pivotal role in understanding the underlying causes of infertility, paving the way for innovative solutions and improved patient care that resonate with couples navigating the complexities of reproductive health.

 

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Fertility Services Market Treatment Type Insights  

The Treatment Type segment of the US Fertility Services Market comprises various methodologies crucial for addressing infertility challenges. Among these, Assisted Reproductive Technology (ART) has garnered significant attention for its effectiveness in pairing with technological advancements, leading to higher success rates in achieving pregnancies. This method often comprises procedures such as in vitro fertilization (IVF), which remains a widely recognized solution for couples facing fertility issues. On the other hand, infertility drugs play a vital role in stimulating ovulation and enhancing fertility outcomes, making them a preferred choice for many seeking less invasive options.

The increasing awareness about fertility treatments and the rising infertility rates in the US are driving this segment's growth. Additionally, factors such as later-in-life pregnancies and lifestyle-related infertility are contributing to the higher demand for these treatments. As the landscape evolves, innovations in ART technologies and drug formulations are anticipated to further enhance treatment efficacy, thereby expanding options for individuals and increasing US Fertility Services Market revenue in the coming years. These dynamics highlight the essential role both ART and infertility drugs hold in the market's overall success and growth.

US Fertility Services Market Key Players and Competitive Insights

The US Fertility Services Market is experiencing significant growth driven by increasing infertility rates, heightened awareness of reproductive health, and advancements in assisted reproductive technologies. The market is characterized by a mix of established healthcare providers and new entrants, focusing on innovative treatments and comprehensive fertility solutions. Competition within this space is intensified by growing consumer demand for personalized care, along with a shift towards transparency in pricing and service offerings. As such, industry players are actively seeking to differentiate their services, enhance patient experiences, and forge partnerships with healthcare systems to expand their reach and capabilities. The landscape is further complicated by the involvement of insurance companies and government policies that shape accessibility and affordability, making it critical for stakeholders to remain agile and adaptive to evolving market dynamics.

UnitedHealth Group stands out in the US Fertility Services Market by leveraging its extensive insurance network and integrated health services model. The company's strengths lie in its ability to provide a comprehensive suite of services, which not only includes fertility treatments but also access to diagnostic testing and counseling services. This holistic approach enables UnitedHealth Group to support patients throughout their fertility journey, thereby improving outcomes and satisfaction. Its large-scale operations allow for economies of scale, enhancing efficiency and reducing costs. Moreover, the company has made significant investments in technology and digital health solutions, facilitating better patient engagement and streamlined service delivery. As a trusted partner in fertility care, UnitedHealth Group continues to expand its market presence, ensuring that it meets the evolving needs of consumers effectively.

Cerner Corporation plays a pivotal role in the US Fertility Services Market by providing advanced health information technology solutions that support fertility clinics and healthcare providers. The company’s key products focus on electronic health records and data management systems specifically designed for reproductive health. Cerner's strength lies in its ability to streamline clinic operations, enhance patient data accessibility, and enable better decision-making through analytics and reporting tools. The company has a strategic focus on partnerships with fertility centers, which aids in improving the integration of care delivery and optimizing clinic performance. Cerner Corporation also engages in mergers and acquisitions to enhance its service offerings, allowing it to incorporate new technologies that meet the unique needs of the fertility sector. With a prominent market presence bolstered by its innovative solutions, Cerner continues to be a vital player in shaping the landscape of fertility services in the United States.

Key Companies in the US Fertility Services Market Include

• UnitedHealth Group


• Cerner Corporation


• Reproductive Medicine Associates of New Jersey


• Shady Grove Fertility


• Fertility and IVF Centers of America


• CCRM Fertility


• The Center for Reproductive Health


• InVitro Fertilization Centers


• California IVF


• Clinica de Reproduccion Asistida


• Boston IVF


• Prelude Fertility


• New Hope Fertility Center


• Fertility Specialists of Texas


• Vios Fertility Institute

US Fertility Services Market Industry Developments

The US Fertility Services Market has been witnessing significant developments recently, primarily driven by advancements in technology and increased awareness regarding fertility treatments. Companies like UnitedHealth Group and Cerner Corporation have been expanding their services to integrate more comprehensive reproductive health solutions. Notably, in September 2023, the Fertility and IVF Centers of America announced a strategic partnership with Prelude Fertility to enhance patient access to IVF services across the nation. The growing market valuation of companies such as Shady Grove Fertility and CCRM Fertility reflects an upward trend, resulting in increased investments aimed at service expansion and technological innovation.

The impact of the COVID-19 pandemic has also led to a rebound in demand for fertility services, with Boston IVF and New Hope Fertility Center reporting higher patient volumes in 2023 compared to previous years. Additionally, the Fertility Specialists of Texas and Vios Fertility Institute have been at the forefront of adopting telehealth services to offer consultations and follow-ups, facilitating greater patient engagement. Overall, the market continues to evolve rapidly with a focus on accessibility and advanced treatment options, supported by substantial investments and partnerships within the sector.

Fertility Services Market Segmentation Insights

• Fertility Services Market Underlying Cause Outlook
  
  
  
  • Male Infertility
  
  
  • Female Infertility
  
  
  
  

• 
  

  Fertility Services Market Treatment Type Outlook

  
  
  
  
  • 
    

    ART

    
    
  
  
  • 
    

    Infertility Drugs

    
    
  
  
  
  

Report Attribute/Metric	Details
Market Size 2023	9.48(USD Billion)
Market Size 2024	10.54(USD Billion)
Market Size 2035	30.19(USD Billion)
Compound Annual Growth Rate (CAGR)	10.044% (2025 - 2035)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Billion
Key Companies Profiled	UnitedHealth Group, Cerner Corporation, Reproductive Medicine Associates of New Jersey, Shady Grove Fertility, Fertility and IVF Centers of America, CCRM Fertility, The Center for Reproductive Health, InVitro Fertilization Centers, California IVF, Clinica de Reproduccion Asistida, Boston IVF, Prelude Fertility, New Hope Fertility Center, Fertility Specialists of Texas, Vios Fertility Institute
Segments Covered	Underlying Cause, Treatment Type
Key Market Opportunities	Telehealth for fertility consultations, Advanced genetic testing innovations, Rising demand for egg freezing, Increased awareness of fertility issues, Expanding male fertility treatment options
Key Market Dynamics	increasing infertility rates, rising awareness programs, technological advancements in treatments, changing societal norms, expanding health insurance coverage
Countries Covered	US